As the VP, Global Franchise Head Lung Cancer, I am responsible for defining strategy, driving growth and maximising performance across AstraZeneca’s diverse lung cancer portfolio.

My passion lies in bridging priorities between the business and health sectors to accelerate a patient-centric business model and shape global health systems to ultimately improve patient outcomes.

I joined AstraZeneca Japan in 2012 and have since held market-level, regional and global roles across geographies, overseeing oncology product lifecycles from development to commercialisation, navigating unique market access issues, and demonstrating alliance leadership, including at the inception of AstraZeneca’s alliance with Daiichi Sankyo. In 2020, I was appointed Co-Chair of the Patient Centricity Steering Committee, an internal working group dedicated to embedding the patient perspective into AstraZeneca’s DNA.

Before joining AstraZeneca, I worked in the consumer goods sector of a multinational organisation, where I oversaw international marketing, sales and business development, and expanded company operations into high-potential markets across four continents.

I received my MBA from the Indian School of Business and hold a Bachelor’s degree in Mechanical Engineering from the Punjab Technical University in India.

What inspires – and humbles – me most in my role is getting to work with some of the brightest minds in science to redefine cancer care and tangibly transform outcomes for patients. If we’re not moving the needle for people living with cancer, we’re not doing our jobs.

Mohit Manrao VP, Global Franchise Head Lung Cancer, Oncology Business Unit

2021 AZ CEO Award

For Phase III results’ publication & global regulatory submissions

2016 Innovation Award

For EGFR therapy launch & access initiatives in Japan

2015, 2017 & 2020 CEO Award

For innovation & successful launches across products


VP, Global Franchise Head Lung Cancer and Tagrisso


Served as Head of Oncology in the UK and of the Daiichi Sankyo Alliance in Europe for AstraZeneca, bringing our innovative oncology portfolio to UK patients, and establishing and commercialising our ADC alliance across Europe


Served as Senior Director of Immuno-Oncology & Lung Cancer for AstraZeneca Japan, launching the first in-country IO in early-stage lung cancer


Served as Therapeutic Area Director Lung Cancer for AstraZeneca Japan, launching an EGFR therapy

Veeva ID: Z4-35197
Date if preparation: July 2021